Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2016

Feb 9, 2016

32130_dirs_2016-02-09_8a287195-9a84-4f62-9cf1-217f98afed14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2016-02-05

Reporting Person: Johnson David Louis (Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-05 Option (Right to Buy) $21.05 A 30000 Acquired 2026-02-04 Common Stock (30000) Direct

Footnotes

F1: At employee's election by a defined date, equity grant may be received as: (a) stock options, (b) restricted stock units at a ratio of 1.6 options for each restricted stock unit, or (c) 50% as stock options and 50% as restricted stock units at a ratio of 1.6 options for each restricted stock unit. Each restricted stock unit represents a right to receive one share of common stock.

F2: This equity grant will vest over four (4) years with one fourth (1/4) of the shares subject to vesting twelve months after the grant date, and one forty-eighth (1/48) of the shares subject to the grant vesting on the last day of each month thereafter.

F3: Not applicable.